Skip nav

For more information, contact:

Rob Seim
Chief Financial Officer
Omnicell, Inc.
800-850-6664, ext. 6478

Julie Hartley
Head of Marketing
MTS Medication Technologies Ltd
0113 2025308

Omnicell, Inc. Closes Acquisition of UK-Based Surgichem Limited

SurgiChem a Leading Provider of Medication Adherence Packaging Solutions to UK Community Pharmacies

MOUNTAIN VIEW, Calif., August 25, 2014 – Omnicell, Inc. (OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced that it has completed the acquisition of Surgichem Limited, a wholly-owned subsidiary of Bupa Care...

Read full release